LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 1 | 37.71 | 27.76 | 1 | 2877 | 0.0003 | -0.3913 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 37.71 | 27.76 | 678 | 2877 | 0.2356 | 0.6116 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 39.41 | 27.76 | 52 | 3105 | 0.0167 | 0.0966 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 39.41 | 27.76 | 672 | 3105 | 0.2164 | 0.5972 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 39.41 | 27.76 | 1 | 3105 | 0.0003 | -0.3864 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 39.41 | 27.76 | 752 | 3105 | 0.2421 | 0.6238 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 41.11 | 27.76 | 64 | 3331 | 0.0192 | 0.1286 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 41.11 | 27.76 | 657 | 3331 | 0.1972 | 0.5811 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 41.11 | 27.76 | 1 | 3331 | 0.0003 | -0.3820 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 41.11 | 27.76 | 760 | 3331 | 0.2281 | 0.6148 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 42.81 | 27.76 | 65 | 3596 | 0.0181 | 0.1289 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 42.81 | 27.76 | 664 | 3596 | 0.1846 | 0.5721 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 42.81 | 27.76 | 1 | 3596 | 0.0003 | -0.3773 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 42.81 | 27.76 | 722 | 3596 | 0.2008 | 0.5910 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 44.52 | 27.76 | 60 | 3884 | 0.0154 | 0.1142 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 44.52 | 27.76 | 658 | 3884 | 0.1694 | 0.5591 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 44.52 | 27.76 | 1 | 3884 | 0.0003 | -0.3726 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 44.52 | 27.76 | 755 | 3884 | 0.1944 | 0.5894 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 46.22 | 27.76 | 67 | 4125 | 0.0162 | 0.1299 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 46.22 | 27.76 | 630 | 4125 | 0.1527 | 0.5414 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 46.22 | 27.76 | 1 | 4125 | 0.0002 | -0.3691 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 46.22 | 27.76 | 714 | 4125 | 0.1731 | 0.5684 | MN20160318_Q01 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 47.93 | 27.76 | 67 | 4421 | 0.0152 | 0.1280 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 47.93 | 27.76 | 696 | 4421 | 0.1574 | 0.5534 | MN20160318_Q01 | E14 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 47.93 | 27.76 | 1 | 4421 | 0.0002 | -0.3651 | MN20160318_Q01 | H08 |